Long COVID in People With and Without HIV

Keri N Althoff, PhD, MPH
Associate Professor, Department of Epidemiology
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University School of Medicine
Baltimore, MD



CME VIDEOTop of page

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:Top of page

Dr. Keri Althoff’s content areas of expertise are the physical and mental comorbidities and multimorbidity in adults aging with HIV, as well as indicators benchmarking progress toward the goals of the Ending the HIV Epidemic initiative in the United States. She is one of two Principal Investigators for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) project. Dr. Althoff also investigates COVID-19, including seroprevalence of antibodies, disparities in testing, positivity, and clinical outcomes, and the post-acute sequelae of SARS-CoV-2 infection. Her methodologic expertise is in designing studies nested in large-scale collaborations of longitudinal cohort studies. Dr. Althoff is serving as the Johns Hopkins University Provost’s Fellow for Research Communication and has been frequently featured in news media translating COVID-19 science and guidelines into everyday life.

Learning Objectives: Top of page

At the completion of this educational session, participants will:
1. Know the most up-to-date definition of long COVID.
2. Be able to describe long COVID phenotypes.
3. Understand hypotheses for mechanisms of long COVID.
4. Be aware of the manifestation of long COVID in people with HIV.

CME Information:Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ for April 20, 2022, as a live activity. This activity will also be available as an enduring activity from April 27, 2022, through April 19, 2025.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians. The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to one (1) Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.

- Dr. Braun (Course Director) has no relevant financial relationships to disclose.

- Dr. Valenti (Moderator) has no relevant financial relationships to disclose.

- Dr. Althoff (Presenter) has no relevant financial relationships to disclose. Dr. Althoff submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from: Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Evaluation

You must be logged in to post a comment. Login | Register